Federally funded research into three deadly viruses could potentially kill millions of people in the process. The research is likely to resume in the new year.

The federal government Tuesday lifted a ban against funding research into the creation of lethal germs. The National Institutes of Health will create expert panels to weigh the cost of the risks involved, says NIH head Dr. Francis S. Collins.

That's very good news for laboratories "interested in understanding the threat of natural pathogens to the human population," James Paulson, a researcher at The Scripps Research Institute, told NPR. Such research can yield clues to better vaccines, The New York Times noted.

Critics, however, warn that research can also create a "monster germ" capable of escaping from a lab and spreading diseases.

In October 2014, all federal funding was halted into efforts to make three viruses (the flu virus, the virus causing Middle East respiratory syndrome, or MERS, and severe acute respiratory syndrome, or SARS) more dangerous.

The new regulations will also apply to any germ or virus that could potentially unleash a pandemic, or the worldwide spread of a new disease.

More of What's Trending on TheStreet:

This article is commentary by an independent contributor. At the time of publication, the author held no positions in the stocks mentioned.

More from Investing

Here Are Two Long-Term Plays That Could Pay Off for Investors

Here Are Two Long-Term Plays That Could Pay Off for Investors

CarMax Is Looking Weak Ahead of Earnings

CarMax Is Looking Weak Ahead of Earnings

Nike Could Trade Lower If It Misses a Step or Breaks Support

Nike Could Trade Lower If It Misses a Step or Breaks Support

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Seagate Technology, Macy's and a Dozen Other Dividend Stocks to Buy Here

Seagate Technology, Macy's and a Dozen Other Dividend Stocks to Buy Here